 Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Pfenex Inc. Pfenex or the Company NYSE American: PFNX breached their fiduciary duties in connection with the proposed sale of the Company to Ligand Pharmaceuticals Incorporated Ligand NASDAQ: LGND. 